In this Section

Histiocytosis Program

In our large and diversely populated Central Valley region, the cancer center has cases of rare diagnoses not always seen even in larger metropolitan areas. Our multidisciplinary team of oncologists, pathologists, radiologists and pediatric surgeons work closely together to determine the best treatment plan for each patient.

Some rare cases we have seen in recent years are:

  • Hemophagocytic Lymphohistiocytosis (HLH)
  • Langerhans Cell Histiocytosis (LCH)
  • Rosai-Dorfman

Led by Dr. David Samuel and co-led by Dr. Faisal Razzaqi, the program sees about 8-10 new patients a year for LCH. We are a member of the North American Consortium for Histiocytosis (NACHO), which provides clinical studies for patients with histiocytic diseases. This membership enables us to open different treatment protocols for kids with LCH, especially those who have failed past treatments or need a second line of treatment.

Learn more about:
Langerhans Cell Histiocytosis